Biochemical Reagent
-
BA6490 HPK1-IN-34Summary: HPK1-IN-34 is a hematopoietic progenitor kinase 1 inhibitor. - BA6491 GNE-6893Summary: GNE-6893 is an orally effective inhibitor.
- BA6492 HPK1-IN-19Summary: An inhibitor of hematopoietic progenitor cell kinase 1.
- BA6493 ZunsemetinibSummary: Zunsemetinib (CDD-450) is an orally active mitogen-activated protein kinase-activated protein kinase 2 pathway inhibitor.
- BA6494 MK2-IN-3Summary: MK2-IN-3 is a potent and selective inhibitor.
- BA6495 MMI-0100Summary: MMI-0100 is a cell-permeable peptide inhibitor that inhibits mitogen-activated protein kinase-activated protein kinase II.
- BA6496 NST-628Summary: NST-628 is a MAPK pathway molecular gel with blood-brain barrier permeability that inhibits phosphorylation and activation.
- BA6497 MS432Summary: MS432 is an innovative, highly selective, degradation agent based on PD0325901 and ligands.
- BA6498 TrametiglueSummary: A derivative.
- BA6500 MS934Summary: MS934 is a new and improved degradation agent for VHL recruitment.